Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone

Bone

Volumn 20, Issue 3, 1997, Pages 259-261

  Devogelaer, J P ^a   Malghem, J ^a   Stasse, P ^a   Nagant De Deuxchaisnes, C ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Bone lesions; Etidronate; Paget's disease; Radiographs; Tiludronate

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; TILUDRONIC ACID;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE LESION; BONE MINERALIZATION; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PAGET BONE DISEASE; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; AGED; DIPHOSPHONATES; DOUBLE-BLIND METHOD; DRUG MONITORING; ETIDRONIC ACID; FEMALE; HUMANS; MIDDLE AGED; OSTEITIS DEFORMANS;

EID: 0030997302     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00368-7     Document Type: Article

References (15)

1. Adamson, B. B., Gallacher, S. J., Byars, J., Ralston, S. H., Boyle, I. T., and Boyce, B. F. Mineralisation defects with pamidronate therapy for Paget's disease. Lancet 342:1459-1460; 1993.
2. Alexandre, C., Meunier, P. J., Edouard, C., Khairi, R. A., and Johnston, C. C. Effects of EHDP (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone. Metab Bone Dis Rel Res 3:309-315; 1981.
3. Coindre, J. M., Edouard, C. M., Arlot, M. E., and Meunier, P. J. Etude histomorphométrique de l'os non pagétique chez le pagétique. Résultats avant et après diphosphonates. Rev Rhum Mal Osteoartic 49:103-109; 1982.
4. Kanis, J. A. and Gray, R. E. Long-term follow-up observations on treatment in Paget's disease of bone. Clin Orthop 217:99-125; 1987.
5. Liens, D., Delmas, P. D., and Meunier, P. J. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953-954; 1994.
6. Maldague, B. and Malghem, J. Dynamic radiologic pattern of Paget's disease of bone. Clin Orthop 217:126-151; 1987.
7. Nagant de Deuxchaisnes, C. Paget's disease of bone: Medical management. In: DeGroot, L. J., Ed. Endocrinology. Philadelphia: WB Saunders; 1989; 1211-1244.
8. Nagant de Deuxchaisnes. C., Devogelaer, J. P., Malghem, J., Maldague, B., and Cornet, F. The effect of the (4-chlorophenyl) thiomethylene disodium bisphosphonate or SR 43119 B in Paget's disease of bone: A radiological study. Calcif Tissue Int 4(Suppl 2):179; 1987.
9. Nagant de Deuxchaisnes. C., Dufour, J. P., Devogelaer, J. P., Huaux, J. P., and Esselinckx, W. Etidronate and the risk of fractures. Lancet i:610-611; 1985.
10. Nagant de Deuxchaisnes, C., Maldague, B., Malghem, J., Devogelaer, J. P., Huaux, J. P., and Rombouts-Lindemans, C. The action of the main therapeutic regimes on Paget's disease of bone, with a note on the effect of vitamin D deficiency. Arthritis Rheum 21:1215-1234; 1980.
11. Nagant de Deuxchaisnes, C., Rombouts-Lindemans, C., Huaux, J. P., Malghem, J., and Maldague, B. Roentgenologic evaluation of the efficacy of calcitonin in Paget's disease of hone. In: MacIntyre, I. and Szelke, B., Eds. Molecular endocrinology. Amsterdam: Elsevier/North-Holland Biomedical; 1977: 213-233.
12. Neer, R. M. Skeletal safety of tiludronate. Bone 17(Suppl):501S-503S; 1995.
13. Roux, C., Gennari, C., Farrerons, J., Devogelaer, J. P., Mulder, H., Kruse, H. P., Picot, C., Titeux, L., Reginster, J. Y., and Dougados, M. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. Arthritis Rheum 38: 851-858; 1995.
14. Snedecor, G. W. and Cochran, W. G. Statistical methods, 6th ed. Ames, IA: Iowa State University Press; 1979.
15. Wimalawansa, S. J. Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study. Am J Med 99:36-42; 1995.